- People should appreciate that hypertriglyceridemia is part of a complex of vascular risk factors that are potentially modifiable, and they all contribute to ischemic stroke risk. So metabolic syndrome includes elevated triglycerides as one of its components. And up until this point, most neurologists recommended lifestyle modifications as the primary intervention to reduce levels of triglycerides. There have been other medications and omega-3 fatty acids that were options, but they weren't well tolerated by patients and they weren't incredibly successful at modifying the risk factor. So having this new agent, which is a purified formulation of omega-3 fatty acids, may be an important contribution to helping minimize risk.